Westmead Dermatology Phase-IV Clinical Trial Studying the Effect of PDE4 Inhibitor on Atopic Dermatitis
Recently, an open competitive grant application by members of the CTSR (Prof Pablo Fernandez-Penas as PI and Dr Ali Azimi as Sub-PI) was approved for funding by Pfizer through its Global Medical Grants Programme. The study is a 1.5 years long Phase IV clinical trial involving the investigation of the effect of nonsteroidal phosphodiesterase 4 …
